granted
on 17 May 2024
Last Applicant/ Owned by
280 Bishopsgate
London
GB
EC2M4RB
Serial Number
97170031 filed on 13th Dec 2021
Registration Number
N/A
Correspondent Address
Lindsay B. Allen
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, pharmaceutical drug dis Read More
Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine earning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services
N/A
N/A
Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development
N/A
N/A
No 97170031
No Service Mark
No 117014-4004
Yes
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
20th Nov 2024 | TEAS PETITION TO AMEND BASIS RECEIVED |
19th Nov 2024 | SOU TEAS EXTENSION RECEIVED |
18th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
17th May 2024 | SOU TEAS EXTENSION RECEIVED |
17th May 2024 | SOU EXTENSION 1 FILED |
17th May 2024 | SOU EXTENSION 1 GRANTED |
19th Apr 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
19th Apr 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
19th Apr 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
21st Nov 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |